NFKB1 and melanoma: The increased production of CCL2, a potent chemokine expressed in the TME, was found to be directly involved in the proliferation of melanoma cells and resistance to apoptosis via NF-κB signaling and hypoxia-inducible factor 1 (HIF1) transcriptional regulation[115].